Cargando…
miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
Prostate cancer (PCa) is the fifth cause of tumor-related deaths in man worldwide. Despite the considerable improvement in the clinical management of PCa, several limitations emerged both in the screening for early diagnosis and in the medical treatment. The use of prostate-specific antigen (PSA)-ba...
Autores principales: | Arrighetti, Noemi, Beretta, Giovanni Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999286/ https://www.ncbi.nlm.nih.gov/pubmed/33805590 http://dx.doi.org/10.3390/pharmaceutics13030380 |
Ejemplares similares
-
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
por: Chakrabortty, Atonu, et al.
Publicado: (2023) -
miRNAs as Therapeutic Tools in Alzheimer’s Disease
por: Lee, Chang Youn, et al.
Publicado: (2021) -
Exosomal miRNAs as cancer biomarkers and therapeutic targets
por: Thind, Arron, et al.
Publicado: (2016) -
Exosomal miRNAs as Biomarkers for Prostate Cancer
por: Hessvik, Nina Pettersen, et al.
Publicado: (2013) -
Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics
por: Roy, Bidisha, et al.
Publicado: (2022)